Howard Federoff

Company: Kenai Therapeutics

Job title: Co-founder and chief medical officer

Seminars:

Expert Discussion: Are Placebo’s Necessary & Ethical when Treatment Includes Invasive Surgeries? 2:30 pm

Centering the patient experience before surgery to empathize with the difficulties in deciding to go forward with these treatments Exploring how effective double-blind trials are in these circumstances, considering that patients will be aware if they did not undergo surgery Discussing ethical concerns regarding placebo testing in the context of regulationRead more

day: Conference Day One

Exploring New Data & Addressing Challenges in Treating Parkinson’s Disease (PD) Using Cell Therapies 9:30 am

Discussing different origins of PD (idiopathic/genetic causes) to understand the scope of the disease Considering which forms of PD would be most suited to being treated with cell therapies Presenting promising data showing improved outcomes for patients with PD treated with cell therapiesRead more

day: Conference Day Two